Research Site

Toulouse, Haute-Garonne 31093

1 studies enrolling now · 7 studies all time

What they study most

Hypophosphatasia (HPP), Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis

Studies at this site

• Registry of Patients With Hypophosphatasia — Enrolling by invitation
• Dimethyl Fumarate (DMF) Observational Study — Completed
• Plegridy Observational Program — Completed
• Efficacy and Safety of BIIB033 (Opicinumab) as an Add-on Therapy to Disease-Modifying Therapies (DMTs) in Relapsing Multiple Sclerosis (MS) — Stopped early
• Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 — Stopped early
• Impact of Natalizumab Versus Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) Participants — Stopped early
• Observational Study to Characterize Real-world Clinical Outcomes With Relapsing-remitting Multiple Sclerosis (RRMS) — Completed